ArticleOncology and therapy2020

A Phase 1, Open-Label Study in Healthy Subjects to Evaluate the Absolute Bioavailability of AG-221 by a Microtracer Approach.

Xiaomin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.